AU Patent

AU2015227534B2 — Peptide slow-release formulations

Assigned to Camurus AB · Expires 2017-02-23 · 9y expired

What this patent protects

A composition for the delayed delivery of a peptide active agent comprising: 1) a salt of said peptide active agent comprising at least one positively charged peptide ion and at least one negatively charged counter-ion ii) a sustained-release delivery vehicle. Wherein said at lea…

USPTO Abstract

A composition for the delayed delivery of a peptide active agent comprising: 1) a salt of said peptide active agent comprising at least one positively charged peptide ion and at least one negatively charged counter-ion ii) a sustained-release delivery vehicle. Wherein said at least 5 one negatively charged counter-ion is a halide ion, preferably a chloride or bromide ion.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015227534B2
Jurisdiction
AU
Classification
—
Expires
2017-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Camurus AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.